Sustained hemoconcentration in patients with chronic atrial fibrillation, a potential risk for stroke and thromboembolic complications. A retrospective study

Japanese Heart Journal

Volumn 39, Issue 6, 1998, Pages 715-720

  Yamada, Hiroko ^a,b   Sugiyama, Takao ^a   Ashida, Terunao ^a   Fujii, Jun ^a  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Hematocrit; Hemoconcentration; Stroke; Thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HEMOCONCENTRATION; HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SINUS RHYTHM; STROKE; THROMBOEMBOLISM;

EID: 0032458028     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.39.715     Document Type: Article

References (18)

1. Wood P. Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation. Br Heart J 1963; 25: 373-82.
2. Schiffrin EL, Gutkowska J, Kuchel O, Cantin M, Genest J. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med 1985; 312: 1196-7.
3. Yamaji T, Ishibashi M, Nakaoka H, Imataka K, Amano M, Fujii J. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias. Lancet 1985; 1: 1211.
4. Zullo MA. Atrial regulation of intravascular volume: observations on the tachycardia-polyuria syndrome. Am Heart J 1991; 122: 188-94.
5. Imataka K, Nakaoka H, Kitahara Y, Fujii J, Ishibashi M, Yamaji T. Blood hematocrit changes during paroxysmal atrial fibrillation. Am J Cardiol 1987; 59: 172-3.
6. Seko Y, Imataka K, Kitahara Y, Fujii J, Long term follow up of blood hematocrit after the transition from sinus rhythm to atrial fibrillation. Jpn J Geriat 1988; 25: 57-8.
7. Takahashi N, Ashida T, Kiraku J, Fujii J. Increase in erythrocyte volume in patients with chronic atrial fibrillation. Jpn Heart J 1997; 38: 387-91.
8. Tohgi H, Yamanouchi H, Murakami M, Kameyama M. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 1978; 9: 369-74.
9. Wannamethee G, Perry IJ, Shaper AG. Hematocrit, hypertension and risk of stroke. J Intern Med 1994; 235: 163-8.
10. Nakaoka H, Imataka K, Kitahara Y, et al. Plasma levels of atrial natriuretic factor in cardiac arrhythmia and congestive heart failure. In: Brenner BM, Laragh JH, editor. American Society of Hypertension Symposium Series Vol 1. Biologically Active Atrial Peptides. New York: Raven Press, 1987: 537-41.
11. Berglund H, Boukter S, Theodorsson E, Vallin H, Edhag O. Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. Br Heart J 1990; 64, 9-13.
12. Williamson JR, Holmberg SW, Chang K, Marvel J, Sutera SP, Needleman P. Mechanisms underlying atriopepsin-induced increases in hematocrit and vascular permeation in rats. Circ Res 1989; 64: 890-9.
13. Fluckiger JP, Waeber B, Matsueda G, Delaloye B, Nussberger J, Brunner HR. Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats. Am J Physiol 1986; 251: H880-3.
14. Naito S, Imataka K, Seko Y, Fujii J. Incidence and occurrence time of cerebral infarction in patients with non-rheumatic atrial fibrillation. Jpn J Stroke 1989; 11: 581-5.
15. Kuramoto K, Matsushita S, Yamanouchi H. Atrial fibrillation as a cause of myocardial and cerebral infarctions. Jpn Circ J 1984; 48: 67-74.
16. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-8.
17. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990; 16: 377-80.
18. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21: 47-51.